Collaborations & Alliances
Related Searches:
Filter by:
526 - 540 of 1095 results
October 22, 2010
Biogen Idec and Genentech, Inc. have amended their antibody collaboration targeting CD20.
Read More »
October 19, 2010
Galapagos has achieved two milestones totaling $3.5 million in its strategic alliances with Janssen Pharmaceutica and GlaxoSmithKline.
Read More »
October 18, 2010
Biocon and Pfizer have entered into a strategic agreement for the worldwide commercialization of Biocon's biosimilar versions of Insulin and Insulin analog products.
Read More »
October 18, 2010
Goodwin Biotechnology, Inc. has signed a development and manufacturing agreement with a multinational biopharmaceutical client, under which Goodwin will develop the process to manufacture a therapeutic monoclonal antibody conjugate for diagnostic imaging
Read More »
October 14, 2010
Charles River Laboratories has entered into an exclusive, long-term marketing and distribution agreement with Transposagen Biopharmaceuticals, Inc., a KY-based provider of genetically modified rat models.
Read More »
October 13, 2010
Genmab has entered an agreement with H. Lundbeck to create and develop human antibody therapeutics for central nervous system (CNS) disorders for three targets identified by Lundbeck.
Read More »
October 11, 2010
Exelixis, Inc. and Bristol-Myers Squibb have entered a collaboration agreement under which Exelixis will grant BMS an exclusive license to its small-molecule TGR5 agonist program, including backups.
Read More »
October 8, 2010
Takeda Pharmaceutical Co. Ltd. and Envoy Therapeutics, Inc., have formed a three-year research alliance aimed at discovering drugs for schizophrenia with greater efficacy and safety than current therapies.
Read More »
October 7, 2010
Takeda Pharmaceuticals North America, Inc. has entered into a multi-year contract with Accenture for a range of information technology (IT) services under a strategic outsourcing contract.
Read More »
October 7, 2010
Quintiles has entered a strategic alliance with the Seoul National University Hospital (SNUH) as part of its Prime Site program.
Read More »
October 5, 2010
Evotec AG and Shionogi & Co Ltd. have entered a fragment-based drug discovery alliance to identify small molecule modulators of various protein-protein interaction targets selected by Shionogi.
Read More »
October 4, 2010
Argenta Discovery Ltd., an affiliate of Galapagos, has entered into a drug discovery service agreement with Janssen Pharmaceutica, related to several cancer drug candidates.
Read More »
September 30, 2010
Avid Bioservices, Inc., a subsidiary of Peregrine Pharmaceuticals, Inc., has entered a biomanufacturing contract to supply clinical material to Affitech A/S over the next year.
Read More »
September 23, 2010
Partnership aims to reach early phase, virtual pharma/biopharma
Read More »
526 - 540 of 1095 results
